Maria Laura Monsalvo - Publications, H-index & Citations

Maria Laura Monsalvo

Amgen Inc

19H指数

61论文数

2.6K被引数

收录论文 25

发表时间

Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition 肥胖相关的心血管风险及PCSK9抑制的获益

JACC

IF0

2025-12-10

OAAI

Yu Mi Kang; Robert P. Giugliano; Anthony C. Keech; J. Antonio G. López; Maria Laura Monsalvo; E. Magnus Ohman; Xinhui Ran; Sabina A. Murphy; Marc S. Sabatine; Michelle L. O’Donoghue

Lipoprotein(a) concentrations across a global cross-sectional registry 脂蛋白(a)浓度全球横断面登记研究

Journal of Clinical Lipidology

IF4.6

2025-05-29

PREAI

Samer Al Said; Xinhui Ran; Julia Kuder; Sabina Murphy; Adam Janas; J. Murray Estess; Kagami Hirabayashi; Christopher Hammett; MB ChB; Andre Faludi; Michail Giakoumis; Emileigh Walsh; Huei Wang; Maria Laura Monsalvo; Helina Kassahun; Marc Sabatine; Michelle O'Donoghue

Association Between Lipoprotein(a) Levels and Incident Complex Coronary Revascularization Procedures in the FOURIER Trial 脂蛋白(a)水平与FOURIER试验中复杂冠状动脉血运重建术发生风险的关联

CIRCULATION

IF38.6

2024-11-12

PREAI

Gaba, Prakriti; O'Donoghue, Michelle; Giugliano, Robert; Bellavia, Andrea; Monsalvo, Maria Laura; Flores-Arredondo, Jose; Kuder, Julia; Atar, Dan; Keech, Anthony; Sabatine, Marc; Bergmark, Brian

LDL-C Lowering with Evolocumab and Arterial Aneurysms: Long-Term Analysis from the FOURIER Trial Evolocumab治疗降低LDL-C与动脉瘤：FOURIER试验的长期分析

CIRCULATION

IF38.6

2024-11-12

PREAI

Gaba, Prakriti; Zimerman, Andre; O'Donoghue, Michelle; Giugliano, Robert; Murphy, Sabina; Kuder, Julia; Monsalvo, Maria Laura; Flores-Arredondo, Jose; Atar, Dan; Keech, Anthony; Sabatine, Marc; Marston, Nicholas; Bergmark, Brian

Long-Term Neurocognitive Safety of LDL-C Lowering With Evolocumab: OpenLabel Extension Data From FOURIER

CIRCULATION

IF38.6

2023-11-07

PREAI

Zimerman, Andre; O'Donoghue, Michelle; Ran, Xinhui; Im, KyungAh; Ott, Brian F.; Mach, Francois; Zavitz, Kenton; Kurtz, Christopher E.; Monsalvo, Maria L.; Wang, Bei; Atar, Dan; Keech, Anthony; Sabatine, Marc S.; Giugliano, Robert

Long-Term Efficacy of Evolocumab in Patients With and Without Multivessel Coronary Artery Disease

CIRCULATION

IF38.6

2023-11-07

PREAI

McClintick, Daniel J.; O'Donoghue, Michelle L.; De Ferrari, Gaetano Maria; Ferreira, Jorge M.; Ran, Xinhui; Im, KyungAh; Lopez, J. A.; Elliott-Davey, Mary; Wang, Bei; Monsalvo, Maria Laura; Atar, Dan

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

CIRCULATION

IF38.6

2023-04-18

PREAI

Gaba, Prakriti; O'Donoghue, Michelle L.; Park, Jeong-Gun; Wiviott, Stephen D.; Atar, Dan; Kuder, Julia F.; Im, KyungAh; Murphy, Sabina A.; De Ferrari, Gaetano M.; Gaciong, Zbigniew A.; Toth, Kalman; Gouni-Berthold, Ioanna; Lopez-Miranda, Jose; Schiele, Francois; Mach, Francois; Flores-Arredondo, Jose H.; Lopez, J. Antonio G.; Elliott-Davey, Mary; Wang, Bei; Monsalvo, Maria Laura; Abbasi, Siddique; Giugliano, Robert P.; Sabatine, Marc S.

Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO (sic) Randomized Clinical Trial

CARDIOLOGY AND THERAPY

IF2.7

2023-02-21

OAAI

Tan, Hong; Li, Weimin; Huang, Zhouqing; Han, Yajun; Huang, Xuecheng; Li, Dongye; Xing, Xiaochun; Monsalvo, Maria Laura; Wu, You; Mao, Jackie; Xin, Lily; Chen, Jiyan

Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a)

CARDIOVASCULAR DRUGS AND THERAPY

IF3.1

2022-11-26

OAAI

Rosenson, Robert S.; Lopez, J. Antonio G.; Monsalvo, Maria Laura; Wu, You; Wang, Huei; Marcovina, Santica M.

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease 已确定的动脉粥样硬化性心血管疾病患者的长期Evolocumab

CIRCULATION

IF38.6

2022-10-11

193

OAAI

O'Donoghue, Michelle L.; Giugliano, Robert P.; Wiviott, Stephen D.; Atar, Dan; Keech, Anthony; Kuder, Julia F.; Im, KyungAh; Murphy, Sabina A.; Flores-Arredondo, Jose H.; Lopez, J. Antonio G.; Elliott-Davey, Mary; Wang, Bei; Monsalvo, Maria Laura; Abbasi, Siddique; Sabatine, Marc S.

Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials evolocumab降低低密度脂蛋白胆固醇的时间平均水平: 2期试验的汇总分析

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2022-07-01

OAAI

Schludi, Belinda; Giugliano, Robert P.; Sabatine, Marc S.; Raal, Frederick J.; Teramoto, Tamio; Koren, Michael J.; Stein, Evan A.; Wang, Huei; Monsalvo, Maria Laura

Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON

CARDIOVASCULAR DIABETOLOGY

IF10.6

2021-04-30

OAAI

Lorenzatti, Alberto J.; Monsalvo, Maria Laura; Lopez, J. Antonio G.; Wang, Huei; Rosenson, Robert S.

Effects of Evolocumab on Low-Density Lipoprotein Cholesterol, Non-High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta-Analysis of Individual Participant Data From Double-Blind and Open-Label Extension Studies

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2021-01-05

OAAI

Daviglus, Martha L.; Ferdinand, Keith C.; Lopez, J. Antonio G.; Wu, You; Monsalvo, Maria Laura; Rodriguez, Carlos J.

Effect of Evolocumab on Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies Evolocumab对非高密度脂蛋白胆固醇，载脂蛋白B和脂蛋白 (a) 的影响: 2期和3期研究的汇总分析

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2020-03-03

OAAI

Toth, Peter P.; Jones, Steven R.; Monsalvo, Maria Laura; Elliott-Davey, Mary; Lopez, J. Antonio G.; Banach, Maciej

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial

DIABETES OBESITY & METABOLISM

IF5.7

2019-04-14

OAAI

Chen, Yundai; Yuan, Zuyi; Lu, Juming; Eliaschewitz, Freddy G.; Lorenzatti, Alberto J.; Monsalvo, Maria Laura; Wang, Nan; Hamer, Andrew W.; Ge, Junbo

Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study

DIABETOLOGIA

IF10.2

2019-04-05

OAAI

Rosenson, Robert S.; Daviglus, Martha L.; Handelsman, Yehuda; Pozzilli, Paolo; Bays, Harold; Monsalvo, Maria Laura; Elliott-Davey, Mary; Somaratne, Ransi; Reaven, Peter

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial

DIABETES OBESITY & METABOLISM

IF5.7

2019-04-02

OAAI

Lorenzatti, Alberto J.; Eliaschewitz, Freddy G.; Chen, Yundai; Lu, Juming; Baass, Alexis; Monsalvo, Maria Laura; Wang, Nan; Hamer, Andrew W.; Ge, Junbo

Efficacy and Safety of Evolocumab in Patients with Type 2 Diabetes Mellitus and Hypercholesterolemia or Mixed Dyslipidemia

DIABETES

IF7.5

2018-07-01

PREAI

Rosenson, Robert S.; Daviglus, Martha L.; Reaven, Peter; Pozzilli, Paolo; Bays, Harold; Monsalvo, Maria Laura; Elliott, Mary; Somaratne, Ransi; Handelsman, Yehuda

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

LANCET

IF88.5

2016-12-01

238

OAAI

Teerlink, John R.; Felker, G. Michael; McMurray, John J. V.; Solomon, Scott D.; Adams, Kirkwood F., Jr.; Cleland, John G. F.; Ezekowitz, Justin A.; Goudev, Assen; Macdonald, Peter; Metra, Marco; Mitrovic, Veselin; Ponikowski, Piotr; Serpytis, Pranas; Spinar, Jindrich; Tomcsanyi, Janos; Vandekerckhove, Hans J.; Voors, Adriaan A.; Monsalvo, Maria Laura; Johnston, James; Malik, Fady I.; Honarpour, Narimon

Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome

DIABETES OBESITY & METABOLISM

IF5.7

2016-10-14

OAAI

Blom, Dirk J.; Koren, Michael J.; Roth, Eli; Monsalvo, Maria Laura; Djedjos, C. Stephen; Nelson, Patric; Elliott, Mary; Wasserman, Scott M.; Ballantyne, Christie M.; Holman, Rury R.

研究方向